DNAG

DNAPrint Genomics, Inc. DNAG

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode DNAG USRM IPAH LADX AVXT MOBO BRAXF REFG MRPI JNHMF
6M 0.00 % -50.00 % 0.00 % -92.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % -75.00 %
YTD 900.00 % 0.00 % 0.00 % -93.91 % 0.00 % 0.00 % -14.67 % 0.00 % 0.00 % -88.89 %
1Y 900.00 % 0.00 % 0.00 % -93.48 % 0.00 % 0.00 % -14.67 % 0.00 % 0.00 % -95.65 %
3Y 900.00 % -97.92 % 409 900.00 % -99.30 % -90.00 % -99.41 % -94.72 % -92.86 % 0.00 % -98.39 %
5Y -99.00 % -98.63 % 409 900.00 % -99.89 % -99.44 % -99.50 % -99.82 % -99.61 % -99.20 % -99.86 %
10Y -99.00 % -99.99 % 40 900.00 % -99.99 % -99.95 % -99.89 % -99.46 % -99.82 % -50.00 % -99.95 %
From the beginning -100.00 % -100.00 % -82.77 % -100.00 % -100.00 % -99.97 % -99.46 % -99.96 % -99.90 % -99.95 %

Dividend

LadRx Corporation